Neupro 2 mg/24h, dispositif transdermique

7680574170311 CH-57417 dispositif transdermique
Neupro 2 mg/24h, dispositif transdermique
Neupro 2 mg/24h, dispositif transdermique
Neupro 2 mg/24h, dispositif transdermique
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Pflaster
Galenic form
dispositif transdermique
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/07/2024
Patient information leaflet
Français
18/07/2024
Patient information leaflet
Italien
18/07/2024
Summary of Product Characteristics
Allemand
18/07/2024
Summary of Product Characteristics
Français
18/07/2024
Summary of Product Characteristics
Italien
18/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
4.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX
(N/A)
- Substance ANTOX
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 75.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2006

Authorization holder

UCB-Pharma SA

1630 Bulle

Authorization information

Swissmedic authorization number
57417
Drug name
Neupro, dispositif transdermique
Galenic form
TRAP
ATC Code
N04BC09
Authorization status
Z
Dispensing category
B
First authorization
27/09/2006
Authorization expiration date
31/12/9999
IT Number
01.08.0.
Domain
Human medicine

Package details

Description (FR)
NEUPRO patch mat 2 mg/24h sach 28 pce
Description (DE)
NEUPRO Matrixpfl 2 mg/24h Btl 28 Stk
Market launch
05/03/2014
Narcotic (BTM)
No

Other package sizes (10)

None
7 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
7 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
7 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
7 PFLA
GTIN: None
Not in V1
None
28 PFLA
GTIN: None
Not in V1
None
7 PFLA
GTIN: None
Not in V1